BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. ✅
Go to Publication ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52 Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y , |
|
|
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. ✅
Go to Publication ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52 Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y , |
|
|
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. ✅
Go to Publication ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52 Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y , |
|
|
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. ✅
Go to Publication ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52 Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y , |
|
|
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 577 Pub: 2016 Epub: 2016 Apr 22 Authors Valdés-Varela L , Alonso-Guervos M , García-Suárez O , Gueimonde M , Ruas-Madiedo P , |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection. ✅
Go to Publication ✅
Journal of microbiology (Seoul, Korea) (J Microbiol ) Vol: 52 Issue 11 Pages: 955-62 Pub: 2014 Nov Epub: 2014 Oct 3 Authors Kim JE , Kim MS , Yoon YS , Chung MJ , Yum DY , |
|
|
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure. ✅
mSphere (mSphere ) Vol: 5 Issue 1 Pages: Pub: 2020 Jan 29 Epub: 2020 Jan 29 Authors Wang K , Lv L , Yan R , Wang Q , Jiang H , Wu W , Li Y , Ye J , Wu J , Yang L , Bian X , Jiang X , Lu Y , Xie J , Wang Q , Shen J , Li L , |
|
|
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure. ✅
mSphere (mSphere ) Vol: 5 Issue 1 Pages: Pub: 2020 Jan 29 Epub: 2020 Jan 29 Authors Wang K , Lv L , Yan R , Wang Q , Jiang H , Wu W , Li Y , Ye J , Wu J , Yang L , Bian X , Jiang X , Lu Y , Xie J , Wang Q , Shen J , Li L , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 1 Pages: Pub: 2023 Dec 29 Epub: 2023 Dec 29 Authors Chen JF , Hsia KC , Kuo YW , Chen SH , Huang YY , Li CM , Hsu YC , Tsai SY , Ho HH , |
|
|
Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 1 Pages: Pub: 2023 Dec 29 Epub: 2023 Dec 29 Authors Chen JF , Hsia KC , Kuo YW , Chen SH , Huang YY , Li CM , Hsu YC , Tsai SY , Ho HH , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 1 Pages: Pub: 2022 Dec 22 Epub: 2022 Dec 22 Authors Shi S , Zhang Q , Sang Y , Ge S , Wang Q , Wang R , He J , |
|
|
Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 1 Pages: Pub: 2022 Dec 22 Epub: 2022 Dec 22 Authors Shi S , Zhang Q , Sang Y , Ge S , Wang Q , Wang R , He J , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. ✅
Go to Publication ✅
Molecular carcinogenesis (Mol Carcinog ) Vol: 61 Issue 10 Pages: 941-957 Pub: 2022 Oct Epub: 2022 Jul 20 Authors Kumar R , Maurya AK , Parker KD , Kant R , Ibrahim H , Kabir MI , Kumar D , Weber AM , Agarwal R , Kuhn KA , Ryan EP , Raina K , |
|
|
Recombinant Bifidobacterium longum Carrying Endostatin Protein Alleviates Dextran Sodium Sulfate-Induced Colitis and Colon Cancer in Rats. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 927277 Pub: 2022 Epub: 2022 Jun 30 Authors Bi Z , Cui E , Yao Y , Chang X , Wang X , Zhang Y , Xu GX , Zhuang H , Hua ZC , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 10 Issue 3 Pages: 1595-1608 Pub: 2019 Mar 20 Epub: Authors Yan S , Yang B , Zhao J , Zhao J , Stanton C , Ross RP , Zhang H , Chen W , |
|
|
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 10 Issue 3 Pages: 1595-1608 Pub: 2019 Mar 20 Epub: Authors Yan S , Yang B , Zhao J , Zhao J , Stanton C , Ross RP , Zhang H , Chen W , |
|
|
Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 80 Issue 11 Pages: 341 Pub: 2023 Sep 15 Epub: 2023 Sep 15 Authors Gong Y , Zhong H , Wang J , Wang X , Huang L , Zou Y , Qin H , Yang R , |
|
|
Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 80 Issue 11 Pages: 341 Pub: 2023 Sep 15 Epub: 2023 Sep 15 Authors Gong Y , Zhong H , Wang J , Wang X , Huang L , Zou Y , Qin H , Yang R , |
|
|
[A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of Helicobacter pylori infection with the inclusion of the probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 ]. ✅
Go to Publication ✅
Terapevticheskii arkhiv (Ter Arkh ) Vol: 93 Issue 8 Pages: 916-922 Pub: 2021 Aug 15 Epub: 2021 Aug 15 Authors Yakovenko EP , Strokova TV , Iakovenko AV , Ivanov AN , Soluyanova IP , Vasilyev NN , |
|
|
Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 18597 Pub: 2020 Oct 29 Epub: 2020 Oct 29 Authors Singh S , Bhatia R , Khare P , Sharma S , Rajarammohan S , Bishnoi M , Bhadada SK , Sharma SS , Kaur J , Kondepudi KK , |
|
|
Oral supplementation of Bifidobacterium longum strain BR-108 alters cecal microbiota by stimulating gut immune system in mice irrespectively of viability. ✅
Go to Publication ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 82 Issue 7 Pages: 1180-1187 Pub: 2018 Jul Epub: 2018 Mar 20 Authors Makioka Y , Tsukahara T , Ijichi T , Inoue R , |
|
|
A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture. ✅
Go to Publication ✅
Canadian journal of microbiology (Can J Microbiol ) Vol: 62 Issue 7 Pages: 623-8 Pub: 2016 Jul Epub: 2016 Mar 4 Authors Rios-Covián D , Sánchez B , Martínez N , Cuesta I , Hernández-Barranco AM , de Los Reyes-Gavilán CG , Gueimonde M , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
The impact of Bifidobacterium longum CCFM1112 on chronic constipation: a randomised, double-blind, placebo-controlled study. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: Issue Pages: 1-17 Pub: 2025 Jul 21 Epub: 2025 Jul 21 Authors Liu W , Wang J , Xue Y , Li J , Huang Y , Zhu S , Wang L , Wang G , Chen W , Zhao J , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
